Stephen Bustin

Stephen Bustin is a Professor of Molecular Medicine at Anglia Ruskin University, UK. He has held multiple academic positions, including Professor of Molecular Science at Queen Mary University of London (2004-2012) and Senior Lecturer/Reader at Barts and The London School of Medicine & Dentistry.

• Academic Ranks: Professor (Molecular Medicine, Anglia Ruskin University, 2014-present)
• Education: PhD in Molecular Genetics, Trinity College Dublin

Research Interests: Bustin's work focuses on improving molecular diagnostic techniques, particularly PCR, with applications in infectious disease testing (e.g., SARS-CoV-2) and cancer biomarkers (e.g., colorectal cancer). He pioneered the MIQE guidelines for standardized qPCR reporting and developed rapid diagnostic assays like CoV2-ID for point-of-care testing.

Publication Trends: Recent articles emphasize PCR standardization, reproducibility challenges, and rapid diagnostic solutions for SARS-CoV-2. His work spans molecular diagnostics, assay design, and scientific integrity, with a strong focus on clinical applications.

Awards:

• 2010: Fellow of the Society of Biology (FSB)
• 2006-2013: Visiting Professor of Molecular Biology, University of Middlesex

Expert Testimony: Bustin served as an expert witness in high-profile trials, including the MMR vaccine-autism class action (2003-2007) and the Lundy murders (2015), where he critiqued flawed molecular evidence.

Grants & Collaborations: While no specific grants are listed, he led international consortia for MIQE guidelines and collaborated with institutions like TATAA Biocenter and Kim-Il-Sung University. His work includes developing rapid PCR assays and debunking misinformation about diagnostic techniques.

Labs & Teams: Bustin's research has been conducted at Anglia Ruskin University, with collaborations in the UK, Switzerland, and New Zealand. He actively promotes transparency in molecular research through his publications and advocacy.